Alamar Biosciences Inc
NAS:ALMRHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG$26.30+4.03%At closeAt close · Tue 20 Oct · ≈ AED 96.59 · Market cap $1.83B · Next earnings Tue 3 Nov
| USD millions | FY2024 | FY2025 |
|---|---|---|
| Revenue | 25.1 | 74.2 |
| Cost of revenue | 16.5 | 32.5 |
| Gross profit | 8.6 | 41.7 |
| Research & development | 39.2 | 37.5 |
| Selling, general & administrative | — | 35.6 |
| Selling & marketing | — | 0.0 |
| Operating expenses | 58.2 | 73.0 |
| Operating income | (49.6) | (31.3) |
| Interest expense | 2.1 | 0.4 |
| Interest income | 4.7 | 2.2 |
| Other income / expense | — | 2.2 |
| Pre-tax income | (47.1) | (29.2) |
| Income tax | 0.0 | 0.7 |
| Net income | (47.1) | (29.8) |
| Discontinued operations | — | 0.0 |
| Other net income adjustments | — | 0.0 |
| EPS, basic (per share) | (0.71) | (0.45) |
| EPS, diluted (per share) | (0.71) | (0.45) |
| EBITDA | (46.4) | (24.9) |
| Depreciation & amortization | 3.2 | 3.9 |
| Weighted average shares (shares) | 66,521,425 | 66,521,424 |
| Weighted average diluted shares (shares) | 66,521,425 | 66,521,424 |
| Gross margin | 34.2% | 56.2% |
| Operating margin | −197.2% | −42.2% |
| Net margin | −187.2% | −40.2% |
USD millionsUpdated Tue 11 Aug ·
ⓘ
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
